Trusted by the world’s leading institutions
The risk of long COVID has declined over the course of the pandemic, although it remains a persistent threat. Researchers from Washington University School of Medicine in St. Louis identified vaccination as a primary factor in reducing the risk of long COVID.
Polyphenols are generally toxic to microorganisms. In peatlands, scientists thought microorganisms avoided this toxicity by degrading polyphenols using an oxygen-dependent enzyme, and thus that low-oxygen conditions inhibit microbes’ carbon cycling.
Insurance coverage, ethnicity and location may all play a role in a person’s ability to receive care after a stroke, according to a study published in the July 17, 2024, online issue of Neurology® Clinical Practice, an official journal of the American Academy of Neurology.
For people with relapsing-remitting multiple sclerosis (MS), a new study has found that the drug ofatumumab is more effective than teriflunomide at helping people across racial and ethnic groups reach a period of no disease activity. The study is published in the July 17, 2024, online issue of Neurology®, the medical journal of the American Academy of Neurology.
Women with endometriosis are four times more likely to develop ovarian cancer, and those with more severe cases are at an even greater risk.
Two studies from Michigan Medicine may provide hope for patients with irritable bowel syndrome struggling to implement the traditional low-FODMAP diet.
New sociological research looks into how and why people sometimes avoid strong ties when facing personal issues. Authors find avoidance is not rare. It is neither limited to specific intimates, nor limited to specific topics. Isolation might be less a matter of having no intimates than of having repeatedly to avoid them.
A group of coffee producers has filmed an extremely rare small carnivore, the Amazon weasel (Neogale africana), near their shade-grown plots as part of a citizen science monitoring program. This species has never previously been recorded in Bolivia.
The UW Medicine-led research focuses on delivering a series of protein packets inside a shuttle vector to replace the defective DMD gene within the muscles. The added genetic code will then start producing dystrophin, the protein lacking in patients with muscular dystrophy.
There’s still much to learn about how doxorubicin, a 50-year-old chemotherapy drug, causes its most concerning side effects. While responsible for saving many lives, this treatment sometimes causes cardiac damage that stiffens the heart and puts a subset of patients at risk for future heart failure. To better understand and potentially control such complications, Tufts University School of Medicine and Tufts Graduate School of Biomedical Sciences researchers have isolated the immune cells that become overactive when patients take doxorubicin.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right